Sun.Nov 10, 2024

article thumbnail

‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer

MedCity News

Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia. While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR T-therapy with properties that could improve safety, efficacy, and durability. The post ‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer appeared first on MedCity News.

FDA 108
article thumbnail

Aignostics leads latest crop of digital health financings

pharmaphorum

Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, Yazen Health, and Nema Health, wearables developer Alimetry, and clinical trial automation startup Research Grid.Digital pathology specialist Aignostics, which develops artificial intelligence algorithms to glean information from medical images and combine it with epidemiological, clinical, and genomic data, has completed a $34 million Series B financing.

Leads 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence

MedCity News

By fostering collaboration and seamless data integration into healthcare systems, the industry is laying the groundwork for a future in which “personalized medicine” is so commonplace within clinical practice that we will just start calling it “medicine.” The post Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence appeared first on MedCity News.

Patients 112
article thumbnail

J&J bids to add smouldering myeloma to Darzalex label

pharmaphorum

Johnson & Johnson looks on course to make Darzalex the first approved drug therapy for smouldering multiple myeloma, after a phase 3 win

86
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

The Trust-Building Playbook: 5 Tips Every Digital Health Marketer Needs to Know

MedCity News

Building trust while simultaneously building products, selling, recruiting, and fundraising can feel impossible. But it’s required whether you have the time or not, and it doesn’t stop no matter how big you grow. The post The Trust-Building Playbook: 5 Tips Every Digital Health Marketer Needs to Know appeared first on MedCity News.

Marketing 107
article thumbnail

Investment surges, hurdles and emerging innovations in neuroscience

Pharmaceutical Technology

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in the field.

More Trending

article thumbnail

Researchers Assess the Role of Vitamin K2 in Managing Nocturnal Leg Cramps

Pharmacy Times

Vitamin K2 displayed a marked reduction in cramp frequency compared to a placebo.

article thumbnail

How Can Healthcare Organizations Earn Trust with Marginalized Communities?

MedCity News

Access to care isn’t enough. Healthcare organizations need to build trust in order to reach underserved communities, experts said on a recent panel. The post How Can Healthcare Organizations Earn Trust with Marginalized Communities? appeared first on MedCity News.